Heptazyme: Phase I

In a Phase I trial of subcutaneous doses of 0.3-90 mg

Read the full 115 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE